Abstract

Chronic obstructive pulmonary disease (COPD) and cystic fibrosis share key clinical features such as chronic airway inflammation and obstructive airflow limitation, and both diseases may lead to chronic respiratory failure and death. Cigarette smoke, well-known to be the major cause of COPD, contributes to suppression of the expression and function of cystic fibrosis transmembrane conductance regulator protein. Likewise, there is evidence that cystic fibrosis transmembrane conductance regulator dysfunction may contribute to key molecular pathways involved in the pathogenesis of COPD. We present 3 adult patients with extensive cigarette smoking histories and COPD who were subsequently diagnosed with cystic fibrosis and describe the management strategy implemented.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.